TrialBritish journal of cancer2014

Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma.

N Bharwani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.